ABOUT US

GenoMar Genetics Group is an international aquaculture breeding and distribution company providing genetically improved tilapia to farmers globally.

From breeding centers in Norway, Asia and Latin America, the company manage innovation and technology programs for some of the most recognized independent brands in the industry such as GenoMar, Aquabel and AquaAmerica.

GenoMar has the most long-standing commitment of professional and innovative breeding work to the tilapia industry. Selection of the GenoMar strain began in the late 1980s.

You have now the opportunity of benefiting from the most efficient genetic material in the market today and accessing exciting new products in the future.

A well developed and expanding production infrastructure enables to quickly disseminate genetic progress and supply year-round, high quality stocks to farmers worldwide, contributing to a sustainable and profitable tilapia aquaculture industry.

Selective breeding program 

GenoMar´s selective breeding program has a long-term strategy to improve the production performance, robustness, and quality of tilapia.

Characteristics of GenoMar breeding program: 

•    Wide genetic diversity and world-class management 

•    Pedigree data and DNA-assisted parental selection 

•    Combined selection. We use a mix of individual and family selection to maximize genetic gain 

•    Control of inbreeding 

We believe strongly on the role of animal breeding to support the efficiency and sustainability of the industry. Therefore, we apply a balanced approach between production and functional traits to deliver our customer with a tilapia stocks that perform well in a variety of conditions: 

– Harvest weight 

– Robustness, including resistance for specific diseases 

– Stress tolerance 

– Fillet yield 

To have a sustainable long term breeding program it is important to control the rate of inbreeding. Too rapid increase of inbreeding level can result in increased disease susceptibility, higher frequency of malformations, loss of performance and ultimately loss of potential for further genetic improvement. 

Scroll to Top